1998-2022 ChinaKaoyan.com Network Studio. All Rights Reserved. 滬ICP備12018245號
分類:導師信息 來源:中國考研網 2016-07-19 相關院校:中國藥科大學
胡加亮,男,出生日期:1973.11.16
研究方向:微生物與生化藥學
具體方向:微生物藥物和生化與生物技術藥物的開發與應用
研究成果:
發表文章:
1.Jialiang Hu, Ming Yan, ChunyanPu, Jingjing Wang, Philippe E. Van den steen, GhislainOpdenakker, HanmeiXu*. Chemically synthesized matrix metalloproteinase- and angiogenesis-inhibiting peptides as anticancer agents. Anti-cancer Reagents ME. 2014 Mar;14(3):483-94.
2.ZhengQiu#, Jialiang Hu#, HanmeiXu, Wenjing Wang, ChunyanPu, Xiang Wang. Generation of anti-tumor peptides by connection of matrix metalloproteinase-9 peptide inhibitor to an endostatin fragment. Anti-Cancer Drugs.2013, 24:677-689.
3.ZhengQiu, Ming Yan, Qian Li, Datao Liu, Philippe E. Van den Steen, Min Wang, GhislainOpdenakker, JialiangHu*. Definition of peptide inhibitors from a synthetic peptide library by targeting gelatinase B/matrix metalloproteinase-9 (MMP-9) and TNF-α converting enzyme (TACE/ADAM-17). J Enzyme Inhib Med Chem. 2012, 27(4):533-40.
承擔課題:
1.十二五國家科技重大專項候選藥物項目:“一類生物新藥抗腫瘤多肽AP25的研究和開發”(2012ZX09103301-004)2012.1-2015.12,在研;
2.2012年國家國際科技合作專項項目“垂體腫瘤干細胞特征分析及抗腫瘤藥物制備的合作研究”(2012BFG32000)2012.1-2014.12,在研;
3.江蘇省創新團隊(教育創新類),2014.1-2016.12,在研。
聯系方式:15005161104(手機);jialiang_hu51@aliyun.com(郵箱)
掃碼關注
考研信息一網打盡